ArticleSignal transduction and targeted therapy2026
Pulmonary surfactant camouflage lipid nanoparticles for efficient mRNA lung delivery.
Weilun Sun, Ti-Qiang Zhou, Yuanyu Huang, Xing-Jie Liang, Fangzhou Li
Abstract readLetter
In one paragraphArticle in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Weilun SunSchool of Life Science, Advanced Research Institute of Multidisciplinary Science, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Beijing Key Laboratory of Mucosal Immunity Vaccines Against Respiratory Viruses, Beijing Institute of Technology, Beijing, PR China.
Ti-Qiang ZhouSchool of Life Science, Advanced Research Institute of Multidisciplinary Science, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Beijing Key Laboratory of Mucosal Immunity Vaccines Against Respiratory Viruses, Beijing Institute of Technology, Beijing, PR China. zhoutiqiang@163.com.
Yuanyu HuangSchool of Life Science, Advanced Research Institute of Multidisciplinary Science, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Beijing Key Laboratory of Mucosal Immunity Vaccines Against Respiratory Viruses, Beijing Institute of Technology, Beijing, PR China. yyhuang@bit.edu.cn.ORCID http://orcid.org/0000-0003-3935-7245 Xing-Jie LiangKey Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences, National Center for Nanoscience and Technology, Beijing, PR China. liangxj@nanoctr.cn.ORCID http://orcid.org/0000-0002-4793-1705 Fangzhou LiState Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, PR China. fzli@bme.pumc.edu.cn.
Funding
China Postdoctoral Science Foundation 2023M740259National Natural Science Foundation of China (National Science Foundation of China) 32171394
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42259790
PMCPMC13247224
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390